Q3 FY2026 · ended Sep 30, 2026 · Revenue $0 · Filed Nov 5, 2026
Neonc Technologies Holdings, Inc. (NTHI) files with the SEC under industry code 2834, Pharmaceutical Preparations. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $0 and a net loss of $4.4 million. As of Sep 30, 2026 it held $6.2 million in cash and investments and $310,214 in total debt.
Revenue
$0
Net income
$-4.44M
+48.5% vs year-ago quarter
Operating cash flow
$-5.09M
+12.4% vs year-ago quarter
Free cash flow
—
EPS
$-0.28
+37.8% vs year-ago quarter
Dividend per share
None
Shares outstanding
28.85M
+48.1% vs year-ago quarter
Net cash
$5.86M
Q3 FY2026
Operating margin
-14273.7%
Q2 FY2025
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NTHI (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Calabasas, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1979414
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | $0 | $0 |
| Operating income | -$5.8M | -$14.1M | -$7.1M | -$13.7M | -$6.9M |
| Net income | -$4.4M | -$14.2M | -$8.8M | -$15.5M | -$8.6M |
| Diluted EPS | -$0.28 | -$0.58 | -$0.38 | -$0.49 | -$0.45 |
| Operating cash flow | -$5.1M | -$4.8M | -$7.0M | -$3.6M | -$5.8M |
| Total assets | $9.3M | $5.2M | $3.3M | $2.8M | $4.1M |
| Total liabilities | $22.5M | $23.8M | $16.6M | $20.3M | $15.9M |
| Stockholders' equity | -$13.2M | -$18.5M | -$13.2M | -$17.5M | -$11.8M |
| Cash and investments | $6.2M | $2.0M | $138,601 | $58,729 | $1.5M |
| Total debt | $310,214 | $328,217 | $346,053 | $361,813 | $378,741 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2026 | Nov 2, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 22, 2026 | Oct 16, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 15, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 28, 2026 | Sep 28, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Sep 21, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 17, 2026 | Sep 16, 2026 |
All 206 Neonc Technologies Holdings, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.